NanoSphere Health Sciences and Stat Shield Technology Form Strategic Partnership to Launch Evolve Products for Veterans
Denver, Colorado, May 02, 2019 (GLOBE NEWSWIRE) -- NanoSphere Health Sciences INC(CSE: NSHS) (OTC: NSHSF), the biotechnology company behind the patented NanoSphere Delivery System™, is pleased to announce that it has signed a Memorandum of Understanding with Stat Shield Technology LLC. A Division of STAT SHIELD ARMOR LLC., where Stat will act as NanoSphere’s exclusive agent for hemp-derived CBD and other products.
Stat’s seasoned specialist and trendsetting Divisions covering the Aerospace, Energy, Finance, Aviation, Tier 1 finance- humanitarian programs both Military and Commercial has helped develop programs instrumental in improving business relations with governmental agencies, resulting in company growth and additional employment opportunities.
NanoSphere Health Sciences has developed products that successfully leverage the next-generation NanoSphere Delivery System™. NanoSphere Health Sciences’ patented technology (US Patent No 9,925,149,and 10,028,919 ) broadly covers the formation and manufacturing of lipid, structural nanoparticles, which is the NanoSphere Delivery System™, for the delivery of cannabinoids, pharmaceuticals, nutraceuticals, cosmeceuticals, and other biological agents. In particular, the IP also extends to 16 forms of lipid nanoparticle structures, which can be applied across healthcare sectors for vastly improved delivery of active pharmaceutical ingredients. NanoSphere recently announced that the Canadian Intellectual Property Office granted a Patent Allowance for Application 2,970,91 for its breakthrough nanoparticle encapsulations of NSAIDs, which paves the way for commercialization for NSAID delivery worldwide.
In the cannabis industry, the company’s revolutionary Transdermal NanoSerum™, is already commercially available throughout Colorado and California and is expanding into several additional U.S. states and countries including Canada. NanoSerum™ delivers cannabinoids through the skin and is ideal for localized or chronic pain and inflammation, as well as providing systemic therapy and relief for insomnia, stress, anxiety and PTSD. The scientifically-proven nano-encapsulation technology significantly increases the bioavailability and is proven safe, fast and significantly decreases side-effects.
This partnership with Stat Shield Technology represents a significant step of growth for NanoSphere Health
said Robert Sutton, Chairman and CEO of NanoSphere Health Sciences.
As a son of a military family, we look forward to bringing our cutting-edge technology to veterans and their families. This rewarding partnership is another important milestone in bringing our patented technology to those who will benefit most from its therapeutic value
Devorah Raney, board member of Stat Shield Technology added
Our team at Stat is rapidly building out an industry leading sales and distribution platform in multiple markets. The success and building blocks for this are our world class team of experts and the best delivery solutions in the business. We couldn’t be more excited to bring the clinically-proven NanoSphere technology embedded in the Evolve brand to this important, often underserved community
For more information or to schedule an interview, please e-mail firstname.lastname@example.org or call 303-324-7358.
On behalf of the Board
Robert Sutton, Chairman and CEO
Victor Goncalves, Executive Vice President
NanoSphere Health Sciences Inc., is a biotechnology firm specializing in the creation of the NanoSphere Delivery System™, a revolutionary platform using nanotechnology for the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. For more information on NanoSphere, please visit http://www.nanospherehealth.com.
About Evolve Formulas
Evolve Formulas, product line developed by NanoSphere Health Sciences, is the provider of the world's first and only scientifically proven nanoparticle delivery system in cannabis. Evolve’s pioneering product, Transdermal NanoSerum™, is a fast-acting, ultra-strength transdermal formula infused with nano-encapsulated cannabis and cannabis extracts. For more information on Evolve Formulas, visit https://www.evolveformulas.com/. Follow us on Facebook, Instagram and Twitter.
About Stat Shield Technology.
STAT is a global organization and veteran of the Aerospace, Aviation Military & Commercial sectors. STAT offers 100-years combined aerospace and aviation industry experience and has developed a team of seasoned, retired military, retired NASA Space, team members and experience which knows the aerospace and aviation industry's bends and quirks. The experience of STAT experts delivers solutions providing the industry with answers to their needs. In 2010 the company’s success story was presented by Department of Defense (DOD) and put on the hill. STAT Mentor Protégé Program has been instrumental in improving small business relations with the US Government resulting in company growth and additional employment opportunities. STAT brings unparalleled service to the marketplace with the philosophy to: meet the company’s demands for maximum operational integrity and assure the safety of the products' it distributes/sells. STAT serves the industry with 24/7/365 (AOG) aircraft on the ground and (J.I.T) Just in Time service programs. STAT professionals can provide this service because of members' advanced credentials in business management and expertise. STAT fields directly related to aircraft, engine repair/overhaul, raw material, military, wheel/brake, (GSE) ground support equipment - and more than a century of combined industry experience in other platforms.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statement Caution
This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company's intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company's future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.